Italia markets close in 6 hours 26 minutes

JNJ May 2024 134.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,03000,0000 (0,00%)
In data: 10:00AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0300
Aperto0,1100
Denaro0,0000
Lettera1,2200
Prezzo d'esercizio134,00
Scadenza2024-05-17
Min-Max giorno0,0300 - 0,1100
Contratto - Min-MaxN/D
Volume1
Open Interest609
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA